SCHEMBL2918582

SCHEMBL2918582

Oc1nc(N2CCN(c3ccccc3)CC2)nc2c1SCC2

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.49
▸ ALDH1A1 P00352 7/20 0.49
▸ HSD17B10 Q99714 3/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ TSHR P16473 6/20 0.43
▸ HPGD P15428 5/20 0.43
▸ SMN1; SMN2 Q16637 4/20 0.43
▸ HTT P42858 3/20 0.43
▸ LMNA P02545 3/20 0.43
▸ USP2 O75604 3/20 0.43
▸ GAA P10253 3/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.40
▸ DCTPP1 Q9H773 1/20 0.39
▸ PDE11A Q9HCR9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2914424 0.89 MAPT (0.41) MAPTALDH1A1HSD17B10KMT2AMEN1
SCHEMBL588576 0.87 KMT2A (0.43) MAPTALDH1A1HSD17B10KMT2AMEN1
SCHEMBL2918449 0.80 HTR2C (0.47) MAPTALDH1A1HSD17B10KMT2AMEN1
SCHEMBL27725837 0.80 MAPT (0.44) MAPTALDH1A1HSD17B10KMT2AMEN1
SCHEMBL2919544 0.78 MAPT (0.42) MAPTALDH1A1HSD17B10KMT2AMEN1
SCHEMBL2916955 0.78 MAPT (0.45) MAPTALDH1A1HSD17B10KMT2AMEN1
SCHEMBL4607882 0.76 MAPT (0.39) MAPTALDH1A1HSD17B10KMT2AMEN1
SCHEMBL3009469 0.76 MAPT (0.39) MAPTALDH1A1HSD17B10KMT2AMEN1
SCHEMBL2916952 0.76 PDE11A (0.42) MAPTALDH1A1HSD17B10KMT2AMEN1
SCHEMBL3026830 0.76 PDE11A (0.43) MAPTALDH1A1HSD17B10KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1874781-B9 DIHYDROTHIENOPYRIMIDINES FOR THE TREATMENT OF INFLAMMATORY DISEASES BOEHRINGER INGELHEIM INT (DE) 2010-09-08 — — EP disclosed
EP-1874781-B1 DIHYDROTHIENOPYRIMIDINES FOR THE TREATMENT OF INFLAMMATORY DISEASES BOEHRINGER INGELHEIM INT (DE) 2009-06-24 — — EP disclosed
EP-2060575-A1 Dihydrothienopyrimidines and their use in treating inflammatory diseases Boehringer Ingelheim International GmbH (DE) 2009-05-20 — — EP disclosed
EP-1874781-A1 DIHYDROTHIENOPYRIMIDINES FOR THE TREATMENT OF INFLAMMATORY DISEASES Boehringer Ingelheim International GmbH (DE) 2008-01-09 — — EP disclosed
WO-2006111549-A1 DIHYDROTHIENOPYRIMIDINES FOR THE TREATMENT OF INFLAMMATORY DISEASES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-10-26 — — WO disclosed
Send feedback